Brief: Oncozenge Q1 2026 Net Sales Operating Loss SEK 6.8 Mln
May 26 (Reuters) - Oncozenge AB ONCOZ.ST: Q1 2026 NET SALES SEK 0 THOUSAND, OPERATING RESULT SEK -6,802 THOUSAND, EPS SEK -0.54 Source text: ID:nMFN3swNnw Further company coverage: ONCOZ.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))